Evan Hecker
8Patents
3h-index
29Co-inventors
57Inventor score
Filing activity: Jul 30, 2003 → Jun 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7132445B2 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | Chemistry; Metallurgy | 36 | Expired |
| US9073829B2 | Synthesis of tetracyclines and intermediates thereto | Chemistry; Metallurgy | 5 | Active |
| US9688644B2 | Synthesis of Tetracyclines and intermediates thereto | Chemistry; Metallurgy | 3 | Active |
| US7691856B2 | Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands | Chemistry; Metallurgy | 1 | Active |
| US11718621B2 | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US10889587B2 | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12098155B2 | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US9120796B2 | B-lactamase inhibitor picoline salt | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.